EPISODE · Oct 20, 2025 · 12 MIN
965 - Weighing the Risks and Benefits of Medication Use During Pregnancy
from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health
About this episode: Prescribing medicine to address fever or pain in pregnancy is a delicate task with a need to consider both potential benefits and risks. In this episode: Obstetrician Dr. Angie Jelin shares how she discusses Tylenol use with expectant parents in the context of emerging evidence and recent news from the federal government. Guests: Dr. Angie Jelin is the assistant director of prenatal genetics at the Prenatal Diagnostic Center in the Division of Maternal-Fetal Medicine and an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Autism Risk Linked to Fever During Pregnancy—Columbia Mailman School of Public Health Interpreting the Data on Tylenol, Pregnancy, and Autism—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
NOW PLAYING
965 - Weighing the Risks and Benefits of Medication Use During Pregnancy
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m